BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6132016)

  • 1. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
    Tsukiyama H; Otsuka K; Horii M; Yoshii Y; Hatori Y; Nakamura Y; Nemoto E; Yamato T; Sakai T; Yamamoto Y
    Jpn Circ J; 1983 Mar; 47(3):313-22. PubMed ID: 6132016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of antihypertensive action of dilevalol compared with that of "cardioselective" beta-blocking agents.
    Strom JA; Vidt DG; Bugni W; Atkins J; Fouad-Tarazi F; Cubbon J; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):25I-33I. PubMed ID: 2729125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G; Grimes D; Muirhead C; Oshiro G
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
    Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
    J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of five beta-adrenoceptor blocking agents on sinoatrial conduction time in isolated blood-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):240-52. PubMed ID: 2862847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of new beta-blockers with vasodilatory properties in essential hypertension.
    Tsukiyama H; Otsuka K; Horii M
    Drugs; 1988; 36 Suppl 6():48-54. PubMed ID: 2908304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle].
    Seguro C; Sau F; Cherchi A
    Cardiologia; 1991 Jan; 36(1):39-45. PubMed ID: 1678985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
    Metelitsa VI; Duda SG; Ostrovskaia TP; Malysheva NV; Lerman OV; Shastun RS; Manoshkina EM; Piotrovskiĭ VK; Rumiantsev DO; Belolipetskaia VG
    Kardiologiia; 1993; 33(4):32-8. PubMed ID: 7933789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
    Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of multiple action agents in hypertension.
    Lund-Johansen P; Omvik P
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S89-95. PubMed ID: 1974512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.